Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T37196 |
5-AAM-2-CP
|
AChR | Neuroscience |
5-AAM-2-CP 是 Acetamiprid 的主要代谢物之一。 Acetamiprid 是一种 nAChR 激动剂,是一种新烟碱类杀虫剂。 | |||
T6685 |
Sulbactam sodium
舒巴坦钠,CP-45899-2 |
Antibacterial; Antibiotic | Microbiology/Virology |
Sulbactam sodium (CP-45899-2) 是一种竞争性、不可逆的 β-内酰胺酶抑制剂。它具有抗菌活性,抑制耐多药不动杆菌-鲍曼不动杆菌复合物。 | |||
T21648 |
CP-31398 dihydrochloride
CP 31398 dihydrochloride |
p53 | Apoptosis |
CP-31398 dihydrochloride 是一种 p53 稳定剂,可稳定 p53 的活性构象并促进具有突变型或野生型 p53 的癌细胞系中的 p53 活性。 | |||
T1218 |
Cefoperazone sodium salt
CP 52640-2,头孢哌酮钠,Cefoperazone sodium |
Antibacterial; Antibiotic | Microbiology/Virology |
Cefoperazone sodium salt (CP 52640-2) 是一种半合成的头孢菌素,具有广谱抗菌活性。 | |||
T1603 |
Glipizide
CP 28720,K 4024,格列吡嗪 |
Potassium Channel; PPAR; ABC | DNA Damage/DNA Repair; Membrane transporter/Ion channel; Metabolism |
Glipizide (CP 28720) 是一种有效的、具有口服活性的磺酰脲类抗糖尿病试剂 (anti-diabetic agent),在 2 型糖尿病的研究中具有价值,但不适用于1 型糖尿病。Glipizide 是通过部分阻断郎格汉斯胰岛细胞中 ATP 敏感钾通道 (KATP)发挥活性 。 | |||
T15259 |
Evatanepag
CP-533536 free acid,2-[3-[N-(4-叔丁基苄基)-N-(吡啶-3-基磺酰基)氨基甲基]苯氧基]乙酸 |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
Evatanepag (CP-533536 free acid) 是一种 EP2 受体选择性前列腺素 E2 (PGE2) 激动剂,可诱导局部骨形成,EC50 为 0.3 nM。它在大鼠骨折愈合模型中以单剂量局部给药时表现出愈合骨折的能力。 | |||
T9032 |
MGH-CP1
|
Others | Others |
MGH-CP1 是 TEAD2 (IC50:710 nM) 及 TEAD4 (IC50:672 nM) 自棕榈酰化抑制剂,口服有活性,可降低细胞内源性或异位表达的 TEAD 蛋白棕榈酰化水平。MGH-CP1 与 Lats1/2 缺失,是 Myc 的表达受到抑制,阻碍上皮细胞过度增殖,诱导细胞凋亡。 | |||
T24598 |
BrBzGCp2
p BrBzGSH(Cp)2,BBGC,pBrBzGSH(Cp)2,p-BrBzGSH(Cp)2,BBGD |
||
p-BrBzGSH(Cp)2 is a glyoxylase 1 inhibitor. In orthotopic mouse models, it acts by increasing DNA-AGEs, stimulating RAGE expression, and inhibiting brain tumor growth. | |||
T35338 |
CP2
|
Histone Demethylase | Chromatin/Epigenetic |
CP2是一种环肽,能够抑制JmjC histone demethylases KDM4,对KDM4A 和KDM4C 的IC50分别为42 nM 和29 nM。 | |||
T31627 |
Englitazone sodium
CP-72,467-2,D03996,CP-72467-2,Englitazone sodium (USAN) |
||
Englitazone sodium is an antidiabetic agent and a novel NSCA and KATP channel blocker. | |||
T71262 |
AZD-8418
|
||
AZD-8418 is an mGlu2 receptor positive allosteric modulators that attenuates nicotine-taking and nicotine-seeking behavior. Acute treatment with AZD8418 (0.37, 1.12, 3.73, 7.46, and 14.92 mg/kg) and AZD8529 (1.75, 5.83, 17.5, and 58.3 mg/kg) deceased nicotine self-administration and had no effect on food-maintained responding. Chronic treatment with AZD8418 attenuated nicotine self-administration, but tolerance to this effect developed quickly. The inhibition of nicotine self-administration by c... | |||
T40295 |
Carindacillin sodium
Carindacillin sodium,CP-15464-2,Carbenicillin indanyl sodium |
||
Carindacillin sodium, also known as Carbenicillin indanyl sodium, is an orally active, broad-spectrum antimicrobial agent. In vivo, it undergoes hydrolysis to Carbenicillin. Carindacillin sodium is specifically utilized in urinary tract infection research. | |||
T74086 |
5-AMAM-2-CP
|
||
5-AMAM-2-CP 是一种 Acetamiprid 的主要代谢产物。Acetamiprid 是一种广泛使用的新烟碱类杀虫剂,是nAChR 的激动剂。 | |||
T10870L |
CP-547632
|
VEGFR; FGFR; PDGFR; BTK | Angiogenesis; Tyrosine Kinase/Adaptors |
CP-547632是一种可口服且具有有效性、ATP 竞争性的 血管内皮生长因子受体2(VEGFR-2 )和 碱性成纤维细胞生长因子(FGF)激酶F 双重抑制剂,IC50 分别为 11 nM 和 9 nM。CP-547632具有选择性,对 VEGFR2 和 bFGF 的选择性高于 EGFR,PDGFRβ 和相关的酪氨酸激酶 (TKs) 。 CP-547632具有抗肿瘤活性。 | |||
T2398 |
Tofacitinib Citrate
CP-690550 citrate,柠檬酸托法替尼,枸橼酸托法替尼,Tasocitinib citrate,Tofacitinib (CP-690550) Citrate |
Apoptosis; Influenza Virus; JAK; Antibacterial; Antifungal | Angiogenesis; Apoptosis; Chromatin/Epigenetic; JAK/STAT signaling; Microbiology/Virology; Stem Cells |
Tofacitinib Citrate (CP-690550 citrate) 是 JAK1/2/3抑制剂,IC50分别为112,20 和 1 nM。它具有抗菌,抗真菌和抗病毒活性。 | |||
T6328 |
Desmethyl Erlotinib
OSI-420,CP-473420,O-Desmethyl Erlotinib |
EGFR; Drug Metabolite | Angiogenesis; JAK/STAT signaling; Metabolism; Tyrosine Kinase/Adaptors |
Desmethyl Erlotinib (CP-473420) 是 Erlotinib 的活性代谢物。Erlotinib 是 EGFR 酪氨酸激酶抑制剂。 | |||
T31020 |
CP 461
OSI 461,UNII-68OJX9I7DT,CP-461,CP461 |
Apoptosis; PDE | Apoptosis; Metabolism |
CP 461 (UNII-68OJX9I7DT) 是一种特异性 PDE2A 抑制剂,是一种新型促凋亡化合物,能抑制环 GMP 磷酸二酯酶,但不能抑制环氧化酶-1 或-2。CP 461 在体外可抑制多种人类肿瘤细胞系的生长,并选择性地诱导癌细胞系而不是正常细胞凋亡。 | |||
T0758 |
Piroxicam
吡罗昔康,CP-16171 |
COX | Immunology/Inflammation; Neuroscience |
Piroxicam (CP-16171) 是一种非甾体抗炎剂,能够抑制COX 的活性,对人单核细胞 COX-1 和 COX-2 的IC50值分别为 47 和 25 μM。 | |||
T22689 |
CP94253 hydrochloride
CP 94253 hydrochloride |
Others; 5-HT Receptor | GPCR/G Protein; Neuroscience; Others |
CP94253 hydrochloride (CP 94253 hydrochloride) 是一种有效的、特异性的和中枢活性的 5-HT1B 受体激动剂,Ki 为 2 nM。5-HT1A、5-HT1D、5-HT1C 和 5-HT2 的 Ki 分别为 89、49、860 和 1600 nM 。 | |||
T37075 |
CB2R PAM
Ec2la |
Cannabinoid Receptor | GPCR/G Protein |
CB2R PAM 是一种口服活性大麻素 2 型受体(CB2Rs)阳性突变调节剂,它能增强 CP 55940 和 2-Arachidonylglycerol 刺激的 [35S]GTPγS 与 CB2 受体的结合,但在没有激动剂的情况下没有作用。CB2R PAM 在神经病理性疼痛小鼠模型中显示出抗损伤活性。 | |||
T17036 |
Tenidap
CP-66248 |
Lipoxygenase | Metabolism |
Tenidap (CP-66248) 是选择性的环氧合酶抑制剂,有抗炎和抗风湿活性,抑制 COX-1 和COX-2 。Tenidap 是一种特异性的 SLC26A3 抑制剂,在颞叶癫痫的毛果芸香碱大鼠模型中具有神经保护作用,可用研究神经系统疾病。 | |||
T6455 |
CP-91149
|
Phosphorylase | Metabolism |
CP91149 是GP (糖原磷酸化酶)的抑制剂,能够促进糖原的重新合成,但不会造成糖原的过度积累。它对2型糖尿病具有潜在的研究价值。 | |||
T31067 |
CP-601932
CP 601932,CP-601932 (free base),CP-601,927,UNII-VI5LR1EU47 |
||
CP-601932 (free base) is a selective base α( 4) β( 2) Nicotinic acetylcholine receptor agonist. | |||
T31048 |
CP-320626
CP 320626 |
||
CP-320626 is an effective inhibitor of glycogen phosphorylase A (LGPA) in the human liver and GPA in the human muscle. Can act synergistically with glucose. It is a possible target for the treatment of type 2 diabetes. | |||
T35915 |
Erlotinib-13C6
Erlotinib-13C6 |
||
Erlotinib-13C6 (CP-358774-13C6) is a 13C-labeled Erlotinib. Erlotinib is a directly acting EGFR tyrosine kinase inhibitor, with an IC50 of 2 nM for human EGFR[1]. Erlotinib reduces EGFR autophosphorylation in intact tumor cells with an IC50 of 20 nM. Erlotinib is used for the treatment of non-small cell lung cancer[1].Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process[2]... | |||
T10870 |
CP-547632 hydrochloride
|
FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
CP-547632 hydrochloride is a well-tolerated and orally-bioavailable inhibitor of the VEGFR-2 and basic FGF kinases (IC50s: 11 nM and 9 nM) with antitumor efficacy. | |||
T21875 |
CP-465022 (maleate)
|
||
CP-465022 Maleate is a potent, selective, noncompetitive AMPA receptor antagonist with anticonvulsant activity. It effectively counters the Kainate-induced response in rat cortical neurons, exhibiting an IC 50 of 25 nM. As such, CP-465022 Maleate presents a valuable instrument for studying the involvement of AMPA receptors in various physiological and pathophysiological processes [1] [2]. | |||
T74000 | CP-547632 TFA | VEGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
CP-547632 TFA是一款口服效果显著的ATP競爭性抑制劑,针对VEGFR-2和FGF激酶具有高度选择性,IC50值分别为11 nM和9 nM。该化合物相较于EGFR和PDGFRβ,对VEGFR2和bFGF展现出更高的选择性,优于相关的酪氨酸激酶(TKs)。CP-547632 TFA还显示了显著的抗肿瘤活性。 | |||
T38204 |
GAT229
|
||
GAT229 is a positive allosteric modulator of cannabinoid receptor 1 (CB1) and the S-(-) enantiomer of the CB1 modulator GAT211. It does not activate the receptor on its own but enhances the binding and activity of CB agonists. GAT229 (1 μM) enhances the binding of the CB1 full agonist CP 55,940 to CHO cells expressing human recombinant CB1 (hCB1), as well as the activity of 2-arachidonoyl glycerol , arachidonoyl ethanolamide , and CP 55,940 in arrestin2 recruitment assays and increases ERK1/2 an... | |||
T83821 |
Thymidine-5'-O-(α,β-methylene)diphosphate sodium
α,β-Methylenethymidine diphosphate,Thymidine-5'-O-methylenediphosphate,TMP-CP,α,β-MTDP |
||
TMP-CP(Thymidine-5’-O-(α,β-methylene)diphosphate)是TDP的一种水解稳定衍生物,同时也是一种thymidine kinase抑制剂(Ki = 23 µM)。它已被用作α,β-methylene-2’-deoxythymidine 5’-triphosphate合成的前体,该合成物是DNA polymerase的一种不可切割底物。 | |||
T4246L |
Varenicline
|
||
Varenicline (CP 526555) 是一种有效的α4β2 nAChR 烟碱乙酰胆碱受体的部分激动剂,EC50值为2.3 μM。Varenicline 是 α3β4 nAChR 和 α7 nAChR 乙酰胆碱受体的完全激动剂,EC50值分别为 55 μM 和 18 μM。Varenicline 是一种基于胞嘧啶结构的烟碱配体,具有戒烟治疗的潜力。 | |||
T61607 |
Laquinimod sodium
|
||
Laquinimod (ABR-215062) sodium 是一种可口服的羧酰胺衍生物,是一种有效的免疫调节剂,可防止中枢神经系统的神经变性和炎症。Laquinimod sodium 减少星形胶质细胞NF-κB 的活化以防止铜酮 (Cuprizone) 诱导的脱髓鞘。Laquinimod sodium 具有用于多发性硬化症 (MS;RRMS 或 CPMS) 的复发缓解 (RR) 和慢性进行性 (CP) 形式以及神经退行性疾病研究的潜力。 |